10% OFF SITEWIDE

00h00m00s
use codeAUGUST10stacks on top of bundle savings
side-by-side research comparison

AOD-9604 vs GLP-3 RTA

AOD-9604 and GLP-3 RTA are both studied in weight research, but they are different classes of compound with different reported research applications.

✓ both US-made · third-party tested · batch COA on every order

at a glance

AOD-9604GLP-3 RTA
compound classModified human growth hormone fragmentSynthetic triple-agonist peptide
research areaweight & metabolicweight & metabolic
purity standard99%+ by HPLC99%+ by HPLC
manufacturedUnited StatesUnited States
batch COApublished per lotpublished per lot
price from$124.99$155.99
availabilityout of stockin stock

what each one is

AOD-9604

Modified human growth hormone fragment

AOD-9604 is a synthetic peptide corresponding to the C-terminal 176–191 fragment of human growth hormone, modified by the addition of a tyrosine residue at the N-terminus to improve stability. Unlike the full-length hormone, the fragment lacks the regions associated with growth-hormone receptor binding, which is what makes it useful as a dissociated structural probe in research.

full AOD-9604 profile →

GLP-3 RTA

Synthetic triple-agonist peptide

GLP-3 RTA is a synthetic single-chain peptide engineered to act at three related class B G-protein-coupled receptors at once: the GLP-1 receptor, the GIP receptor, and the glucagon receptor. Its backbone is derived from the incretin peptide family and carries a fatty-acid modification that extends plasma half-life in pre-clinical systems, making it a widely cited reference agonist in incretin-receptor research.

full GLP-3 RTA profile →

where the research differs

Both compounds are supplied strictly for laboratory research use only. Reported research contexts for each:

AOD-9604

  • Lipid-metabolism and adipocyte-signaling research models
  • Growth-hormone fragment structure–activity research
  • Lipolytic and lipogenic enzyme pathway studies
  • Comparative studies against full-length growth hormone
  • Body-composition research endpoints in pre-clinical models

GLP-3 RTA

  • GLP-1, GIP, and glucagon receptor agonism research
  • cAMP and class B GPCR signaling research models
  • Comparative single-, dual-, and triple-agonist pharmacology studies
  • Metabolic-pathway and nutrient-handling research models
  • Peptide half-life, lipidation, and stability research

shop either compound

AOD-9604currently out of stock
GLP-3 RTAfrom $155.99

Any 2 different compounds take 20% off, any 3 take 30% — applied automatically in the cart, no code. Orders placed Monday–Friday ship by 2pm CT, free over $100.

build a stack with both →

frequently asked

What is AOD-9604?

AOD-9604 is a synthetic peptide based on the 176–191 C-terminal fragment of human growth hormone, with an added N-terminal tyrosine. Verve supplies it as a research compound for laboratory use only, not for human or veterinary use.

What is AOD-9604 studied for in research?

It is used as a reference compound in lipid-metabolism, adipocyte-signaling, and enzyme-pathway research, and in structure–activity studies comparing fragments to full-length growth hormone. Verve makes no claims about use in humans or animals.

What is GLP-3 RTA?

GLP-3 RTA is a synthetic peptide that acts as an agonist at three receptors — GLP-1, GIP, and glucagon. Verve supplies it as a research compound for laboratory use only, not for human or veterinary use.

What is GLP-3 RTA studied for in research?

In in-vitro and pre-clinical models it is used as a reference agonist in incretin-receptor pharmacology, cAMP signaling, and metabolic-pathway research. Verve makes no claims about use in humans or animals.

related comparisons

verve products are sold for laboratory research and development purposes only and are not intended for human or veterinary use of any kind. statements on this site have not been evaluated by the FDA.